Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
368,692
-
Shares change
-
+136,909
-
Total reported value, excl. options
-
$1,179,838
-
Value change
-
+$438,113
-
Number of buys
-
7
-
Number of sells
-
4
-
Price
-
$3.20
Institutional Holders of Predictive Oncology Inc. - COM (POAI) as of Q3 2023
As of 30 Sep 2023 Predictive Oncology Inc. - COM (POAI) had 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 368,692 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, RAYMOND JAMES & ASSOCIATES, GEODE CAPITAL MANAGEMENT, LLC, RB Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, OSAIC HOLDINGS, INC., and Tower Research Capital LLC (TRC).
This table shows 15 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.